While its biological function and tumor pathogenesis in human cancer are not fully understood, studies have found that FJX1 is highly expressed in several types of cancer, including head and neck cancer, colon cancer, breast cancer, ovarian cancer, and lung cancer (14–18). Here, FJX1 is linked to neoplasm.